These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 22029953)

  • 1. Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.
    Heyman E; Gamelin FX; Goekint M; Piscitelli F; Roelands B; Leclair E; Di Marzo V; Meeusen R
    Psychoneuroendocrinology; 2012 Jun; 37(6):844-51. PubMed ID: 22029953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.
    Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V
    Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.
    Hill MN; Miller GE; Carrier EJ; Gorzalka BB; Hillard CJ
    Psychoneuroendocrinology; 2009 Sep; 34(8):1257-62. PubMed ID: 19394765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an acute consumption of a moderate amount of ethanol on plasma endocannabinoid levels in humans.
    Feuerecker M; Hauer D; Gresset T; Lassas S; Kaufmann I; Vogeser M; Briegel J; Hornuss C; Choukèr A; Schelling G
    Alcohol Alcohol; 2012; 47(3):226-32. PubMed ID: 22278319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder.
    Meyer JD; Crombie KM; Cook DB; Hillard CJ; Koltyn KF
    Med Sci Sports Exerc; 2019 Sep; 51(9):1909-1917. PubMed ID: 30973483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes.
    Thompson Z; Argueta D; Garland T; DiPatrizio N
    Physiol Behav; 2017 Mar; 170():141-150. PubMed ID: 28017680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
    Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
    Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
    Hanlon EC
    Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible Anandamide and Palmitoylethanolamide involvement in human stroke.
    Naccarato M; Pizzuti D; Petrosino S; Simonetto M; Ferigo L; Grandi FC; Pizzolato G; Di Marzo V
    Lipids Health Dis; 2010 May; 9():47. PubMed ID: 20470384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
    Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R
    Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
    Gatta-Cherifi B; Matias I; Vallée M; Tabarin A; Marsicano G; Piazza PV; Cota D
    Int J Obes (Lond); 2012 Jun; 36(6):880-5. PubMed ID: 21844878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.
    Côté M; Matias I; Lemieux I; Petrosino S; Alméras N; Després JP; Di Marzo V
    Int J Obes (Lond); 2007 Apr; 31(4):692-9. PubMed ID: 17224929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa.
    Monteleone AM; Di Marzo V; Aveta T; Piscitelli F; Dalle Grave R; Scognamiglio P; El Ghoch M; Calugi S; Monteleone P; Maj M
    Am J Clin Nutr; 2015 Feb; 101(2):262-9. PubMed ID: 25646322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabimimetic effects of osteopathic manipulative treatment.
    McPartland JM; Giuffrida A; King J; Skinner E; Scotter J; Musty RE
    J Am Osteopath Assoc; 2005 Jun; 105(6):283-91. PubMed ID: 16118355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
    Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
    Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report.
    Hill MN; Miller GE; Ho WS; Gorzalka BB; Hillard CJ
    Pharmacopsychiatry; 2008 Mar; 41(2):48-53. PubMed ID: 18311684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Anandamide and Decreased Pain and Depression after Exercise in Fibromyalgia.
    Stensson N; Gerdle B; Ernberg M; Mannerkorpi K; Kosek E; Ghafouri B
    Med Sci Sports Exerc; 2020 Jul; 52(7):1617-1628. PubMed ID: 32168104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasma levels of the endocannabinoid, anandamide, increase with the induction of labour.
    Nallendran V; Lam PM; Marczylo TH; Bankart MJ; Taylor AH; Taylor DJ; Konje JC
    BJOG; 2010 Jun; 117(7):863-9. PubMed ID: 20406230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids in chronic migraine: CSF findings suggest a system failure.
    Sarchielli P; Pini LA; Coppola F; Rossi C; Baldi A; Mancini ML; Calabresi P
    Neuropsychopharmacology; 2007 Jun; 32(6):1384-90. PubMed ID: 17119542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma endocannabinoid levels in multiple sclerosis.
    Jean-Gilles L; Feng S; Tench CR; Chapman V; Kendall DA; Barrett DA; Constantinescu CS
    J Neurol Sci; 2009 Dec; 287(1-2):212-5. PubMed ID: 19695579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.